We believe that every woman has the right to know her body...
Not just once a year, but every day in between.
The Mission
Most women wait 1 to 3 years between breast examinations. This gap is precisely where the uncertainty lies.
URLuminous was founded to close this gap. The Luminous Pro Series offers women a visual overview of their own breast health – at home, in minutes, and without radiation exposure. Not to replace medical care, but to supplement it.
So that the time between examinations feels less like waiting and more like mindfulness.
Our mission is to provide hope, protection, and well-being to women everywhere by making breast health awareness accessible, visual, and continuous.
The Founder
A personal story. A worldwide mission.
At 17, Marylin Dans felt a lump in her breast. Surgery followed. The lump was benign – but this experience never left her.
Thirty years later, as a mother of twin boys and a committed citizen, she used this experience to create something that could protect women who would otherwise never have access to the necessary tools.
The result is the Luminous Pro Series. Not just a device – but a way to live consciously.
Marylin Dans, CEO and Founder
Advisory board members
Mr. Lin Chang PHDs, MBA
Award-winning, globally recognized expert in diode laser technology; 20 years of experience in engineering technologies; Winner of the Deloitte Technology Fast 50 2016; Winner of the APAC 2022 Top 10 Aesthetic Device Provider.
Sharon Wolfington
Board Member - CEO of AdvaMed - President of Acumed - DJO Recovery Services Highly experienced senior executive and board member with over 30 years of experience in medical devices and healthcare.
Dr. Ira Lawrence MD
REGULATORY ADVISOR CAREER HIGHLIGHTS: CMO - Alphaeon Corporation CMO - Medisis Extensive experience in all phases of global product development from pre-clinical through Phase 4.
Dr Alaknanda Dhotre MD MBA
CAREER HIGHLIGHTS IN QUALITY CONTROL & REGULATORY AFFAIRS: CEO at ANDglobal Solutions Inc. (Canada), Consultant at VCollab Inc. (Toronto), Leadership positions at Biocon & Becton & Dickinson, Academic gold medalist, Author, Extensive experience in Medical Affairs, International Regulatory Affairs, and Quality Management Systems
Glenn Normoyle
Commercialization Consultant & President - NeoGraft® Solutions EXIT: Sale to Venus Concept Extensive experience in Medical Device and Healthcare Consumer Product sales and marketing, from launch to exit, in both Direct-to-Consumer (DTC) and B2B environments.
collaborating physicians and scientists
Dr. John P. Diaz, MD
Chief of Gynecologic Oncology, Physician Leader of Clinical Trials at Miami Cancer Institute, and Director of the Minimally Invasive Gynecologic Surgery Center of Excellence, BHSF.
Dr Rafael J Perez Facog
He is a board-certified obstetrician-gynecologist and a urogynecologist. He earned his bachelor's degree at Harvard University and the University of Puerto Rico School of Medicine, and completed his residency at Johns Hopkins University.
Dr Fernando Ocasio-Villa MD, MBBS
He is an acclaimed scientist and researcher with over ten years of experience in oncology, neurological clinical trials, genetic and observational studies, and the development of artificial intelligence for medical devices.
Dr. Moises D. Irizarry-Roman, MD
He specializes in family medicine, sports medicine, and regenerative medicine. Since 2001, he has been a key medical consultant for LPS.
Dr Orlando Silva MD
Dr. Silva is a board-certified hematologist and oncologist specializing in breast cancer. After graduating from Northwestern University Medical School, Dr. Silva completed his fellowship in hematology and oncology at Duke University.
Important Information
Luminous Pro Series is a CE Class I medical device in the EU and UK.
Read our Declaration of Conformity
Read our Clinical Trials and Peer Review
Read our User Protocol
DISCLAIMER (Luminous Pro Series, Locked): The Luminous Pro Series is not a diagnostic device. It is intended as a supplementary aid for breast health awareness alongside clinical examinations or self-examinations - and not a substitute for regular check-ups or doctor's visits. While abnormalities may appear as dark shadowed areas, 9 out of 10 tumors are benign. Any new or unusual changes in the breast should always be investigated by a medical professional.